Starting your career in Houston? You're in the right place. Photo via Pexels

First-time job hunters are facing a competitive job market with historic unemployment and an unstable economy amid the coronavirus pandemic. However, Houston, according to a recent report, might give its residents an advantage.

The report, released May 20 by career website LinkedIn, places Houston at No. 10 on a list of the places in the U.S. that are best suited for new college graduates who are diving into the job market. The list comes out as recent grads confront a job market that's "shaping up to become one of the worst in recent memory," according to The Hechinger Report, a nonprofit news outlet that covers education.

LinkedIn considered three factors for its ranking: affordable rent, good starting salaries, and job availability. Houston's median rent sits at $1,377 per month (all types and sizes of rental properties), LinkedIn says, while its median annual salary for entry-level "career starter" jobs stands at $69,800.

Two other Texas metros appear in the top 15:

  • No. 13 San Antonio, where the median rent is $1,219 and the entry-level salary is $59,900
  • No. 15 Dallas-Fort Worth, where the median rent is $1,423 and the entry-level salary is $65,300

Austin, consistently touted as a magnet for college grads, failed to make the LinkedIn cut.

"What you [also] won't find on this list are the traditional coastal job magnets — New York, the Washington, D.C. area, the San Francisco Bay Area, and Los Angeles," LinkedIn points out. "Those cities may still offer some of the highest starting salaries, but their sky-high rents mean income doesn't stretch nearly as far."

Among the top occupations in the metro areas on LinkedIn's list are software engineer, registered nurse, teacher, project manager, project engineer, consultant, and analyst.

It might be difficult to find those jobs, though. The Conference Board, a research group that monitors business trends, says the number of new job postings in Texas declined from 255,000 in March to 175,000 in April.

To deal with the current economic realities, some new college grads are making sacrifices. In a survey by Monster.com and Wakefield Research, 55 percent of graduating seniors indicated they'd applied for a job they knew wasn't a good fit, and 52 percent said they would accept a lower salary.

"They're feeling desperate," Vicki Salemi, a career expert at Monster.com, told The Hill news website.

------

This article original ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.